Gabelli Research Analysts Raise Earnings Estimates for Orthofix International N.V. (OFIX)

Orthofix International N.V. (NASDAQ:OFIX) – Analysts at Gabelli increased their FY2020 EPS estimates for shares of Orthofix International N.V. in a report released on Wednesday. Gabelli analyst J. Tsai now expects that the medical device company will post earnings of $2.20 per share for the year, up from their prior estimate of $2.05.

OFIX has been the topic of a number of other reports. Jefferies Group LLC reiterated a “buy” rating and issued a $55.00 target price (up from $50.00) on shares of Orthofix International N.V. in a research report on Thursday, August 10th. Zacks Investment Research upgraded Orthofix International N.V. from a “hold” rating to a “buy” rating and set a $60.00 target price on the stock in a research report on Thursday. BidaskClub downgraded Orthofix International N.V. from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, July 25th. TheStreet downgraded Orthofix International N.V. from a “b” rating to a “c+” rating in a research report on Tuesday, October 31st. Finally, BTIG Research set a $56.00 target price on Orthofix International N.V. and gave the stock a “buy” rating in a research report on Monday, October 30th. Seven analysts have rated the stock with a buy rating, Orthofix International N.V. has a consensus rating of “Buy” and a consensus price target of $54.42.

COPYRIGHT VIOLATION WARNING: This piece of content was published by Community Financial News and is owned by of Community Financial News. If you are viewing this piece of content on another domain, it was stolen and republished in violation of U.S. & international trademark and copyright legislation. The original version of this piece of content can be accessed at https://www.com-unik.info/2017/11/06/gabelli-research-analysts-raise-earnings-estimates-for-orthofix-international-n-v-ofix.html.

Orthofix International N.V. (NASDAQ OFIX) traded down $0.10 during trading on Monday, hitting $51.79. The company had a trading volume of 68,258 shares, compared to its average volume of 160,616. The firm has a market capitalization of $946.01, a price-to-earnings ratio of 33.92, a P/E/G ratio of 2.57 and a beta of 0.15. Orthofix International N.V. has a one year low of $32.51 and a one year high of $54.33.

Orthofix International N.V. (NASDAQ:OFIX) last posted its quarterly earnings data on Monday, October 30th. The medical device company reported $0.42 EPS for the quarter, topping the Zacks’ consensus estimate of $0.41 by $0.01. The company had revenue of $105.30 million for the quarter, compared to analyst estimates of $100.67 million. Orthofix International N.V. had a return on equity of 10.26% and a net margin of 0.33%. The firm’s quarterly revenue was up 6.9% on a year-over-year basis. During the same period in the previous year, the firm earned $0.36 earnings per share.

A number of hedge funds have recently modified their holdings of the business. Vanguard Group Inc. raised its position in Orthofix International N.V. by 18.6% during the first quarter. Vanguard Group Inc. now owns 1,815,948 shares of the medical device company’s stock valued at $69,278,000 after purchasing an additional 284,482 shares during the period. Dimensional Fund Advisors LP raised its position in Orthofix International N.V. by 11.6% during the second quarter. Dimensional Fund Advisors LP now owns 870,120 shares of the medical device company’s stock valued at $40,443,000 after purchasing an additional 90,349 shares during the period. State Street Corp raised its position in Orthofix International N.V. by 4.1% during the second quarter. State Street Corp now owns 481,220 shares of the medical device company’s stock valued at $22,370,000 after purchasing an additional 18,741 shares during the period. Northern Trust Corp raised its position in Orthofix International N.V. by 5.8% during the second quarter. Northern Trust Corp now owns 350,019 shares of the medical device company’s stock valued at $16,269,000 after purchasing an additional 19,253 shares during the period. Finally, Teachers Advisors LLC raised its position in Orthofix International N.V. by 15.9% during the second quarter. Teachers Advisors LLC now owns 320,404 shares of the medical device company’s stock valued at $14,892,000 after purchasing an additional 44,064 shares during the period. Institutional investors and hedge funds own 93.81% of the company’s stock.

In other Orthofix International N.V. news, CFO Rice Doug sold 7,353 shares of the company’s stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $49.46, for a total transaction of $363,679.38. Following the sale, the chief financial officer now directly owns 44,743 shares in the company, valued at $2,212,988.78. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Bradley V. Niemann sold 6,956 shares of the company’s stock in a transaction that occurred on Monday, September 11th. The shares were sold at an average price of $49.44, for a total value of $343,904.64. Following the sale, the insider now owns 40,178 shares in the company, valued at $1,986,400.32. The disclosure for this sale can be found here. Insiders sold 23,406 shares of company stock worth $1,138,531 over the last quarter. 5.60% of the stock is owned by company insiders.

Orthofix International N.V. Company Profile

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.

Earnings History and Estimates for Orthofix International N.V. (NASDAQ:OFIX)

What are top analysts saying about Orthofix International N.V.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Orthofix International N.V. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit